Whole-body HSD17β11 deletion in mice did not impact fatty acid metabolism in the liver or hepatic steatosis, and exerted few phenotypic changes, which included a very modest increase in body mass and energy expenditure in female mice and a minor increase in carbohydrate oxidation in male mice. The gene discussed is HSD17B11; the disease is fatty liver disease.